Know Cancer

or
forgot password

Effect of Hydroxyethyl Starch on Renal Handling of Sodium and Water, Vasoactive Hormones,Biomarkers and the Circulatory System in Patients Undergoing Radical Prostatectomy


Phase 4
18 Years
N/A
Open (Enrolling)
Male
Prostate Cancer

Thank you

Trial Information

Effect of Hydroxyethyl Starch on Renal Handling of Sodium and Water, Vasoactive Hormones,Biomarkers and the Circulatory System in Patients Undergoing Radical Prostatectomy


Hydroxyethyl starch (HES) is widely used in hospitals to maintain circulation in critically
ill patients. In recent years studies have raised suspicion that HES is nephrotoxic. So far
acute kidney injury has been diagnosed based on creatinine measurements, but new technology
allows for earlier diagnosis using measurements of biomarkers in urine.

The purpose of this project is to investigate HES's potential toxicity and effects on the
circulation and kidneys using measurements of biomarkers specific for toxicity and for the
sodium/water balance in the urine and by measurements of vasoactive hormones in the blood
after administration of HES 130/0.4


Inclusion Criteria:



- Age > 18 years

- Males

- Indication for radical prostatectomy

Exclusion Criteria:

- Blood donation within the last month

- Lack of wish to participate

- eGFR< 15ml/min

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Diagnostic

Outcome Measure:

u-NGAL

Outcome Description:

The main objective for the trial (only patients undergoing elective radical prostatectomy) is to measure the effect of hydroxyethyl starch on u-NGAL, which is a biomarker of nephrotoxicity

Outcome Time Frame:

2-4 hours

Safety Issue:

Yes

Principal Investigator

Anne Sophie P. Kancir, MD PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Holstebro Regional Hospital

Authority:

Denmark: Danish Medicines Agency

Study ID:

ASK-2-2011

NCT ID:

NCT01486563

Start Date:

January 2012

Completion Date:

June 2013

Related Keywords:

  • Prostate Cancer
  • Prostatic Neoplasms

Name

Location